Delivery Order SPE2DB20D1100-SPE2DB25FE6W9
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Loestrin 21 1-20 tablets in quantities of 21 units. This is a firm fixed-price delivery order with a ceiling value of $47,164.04 and a completion date of September 8, 2025. The award was made through open competition with no set-aside designation, and the place of performance is located in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a delivery order valued at $4,248.51 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 tablets (21-tablet supply) on September 4, 2025, with completion scheduled for September 5, 2025. This competitive award, issued without set-aside designation, represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $3,336.32 to AmerisourceBergen Drug Corp for Loestrin 21 1.5-30 tablets (21-tablet supply) on July 31, 2025, with ultimate completion by August 1, 2025. This is a firm fixed price, non-set-aside delivery order supporting federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,838.58 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 Tablet (21-count packages) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive award, which received no set-aside designation, represents a firm fixed-price delivery order to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child award issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,816.41 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1.5-30 tablets (21-count package). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Loestrin 21 1-20 tablets (21-count packages) under a firm fixed-price contract with a ceiling value of $3,580.26. This non-competitive delivery order is expected to be completed by August 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Loestrin 21 1.5-30 tablets (21-count packages) valued at $8,991.35 under a firm fixed-price contract type. The award, announced on June 9, 2025, with an ultimate completion date of June 10, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location, supplying this...
- The Defense Logistics Agency awarded a delivery order valued at $2,898.32 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1-20 tablets (21-count packages) on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,386.80 by the Defense Logistics Agency's Medical Supply Chain on July 15, 2025, for the supply of Loestrin 21 1-20 tablets in quantities of 21 units. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. This delivery order will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 16, 2025. The award is...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Loestrin 21 1-20 Tablet in quantities of 21 units. This is a firm fixed-price delivery order with a ceiling value of $1,790.10 and an ultimate completion date of August 15, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform all work at...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE6W9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,133.43 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 tablets (21-count packages) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order, which carried no set-aside designation, will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under a larger Indefinite Delivery Contract vehicle. This delivery order falls under AmerisourceBergen Drug Corp's SPE2DX Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply agreement running through December 2026 that supports military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, supplies an extensive range of medical products including brand-name and generic medications, vaccines, and specialized medical supplies to federal customers including the Defense Health Agency and U.S. Coast Guard. The company's consistent receipt of competitively awarded contracts across multiple therapeutic domains demonstrates its capability to meet federal procurement requirements and support critical defense healthcare supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/15/25 |